Ali Javaheri, MD, PhD Assistant Professor of Medicine

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Reprieve
    Topic:
    clinical trial
    Date added:
    12/04/2025
    Date updated:
    12/04/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Alleviant
    Topic:
    clinical trial heart failure
    Date added:
    12/04/2025
    Date updated:
    12/04/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Bitterroot Bio
    Topic:
    doxorubicin
    Date added:
    12/04/2025
    Date updated:
    12/04/2025
  • Attribution:
    Self
    Type of financial relationship:
    Intellectual Property Other
    Ineligible company:
    Mobius
    Topic:
    eye disease / apoM
    Date added:
    12/04/2025
    Date updated:
    12/04/2025
Return to 234 Cardio-Oncology Conference "Translational insights into doxorubicin cardiomyopathy: cellular and organ crosstalk" (010926)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.